About
Certara Inc (NASDAQ:CERT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
Apr 9 2026
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
Mar 3 2026
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Feb 26 2026
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
Jan 29 2026
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Financials
Revenue
$418.84 M
Market Cap
$869.63 M
EPS
-0.01
Google Übersetzer